Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$160.7M
5 rounds on record
Latest round
$90.8M
Venture round · Dec 2024 · 21 mo ago
Backers
1
Broadview Ventures
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 19, 2024
Raised a round Venture round $90.8M · SEC Form D
Jan 24, 2023
Raised a round Venture round $43.9M · SEC Form D
May 1, 2020
Raised a round Venture round $13M · SEC Form D
May 1, 2020
Raised a round Venture round $13M · SEC Form D
Dec 19, 2017
Took on debt financing $1.1M · SEC Form D
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2024 | $90.8M | — | SEC Form D |
| Venture round | Jan 2023 | $43.9M | — | SEC Form D |
| Venture round | May 2020 | $13M | — | SEC Form D |
| Venture round | May 2020 | $13M | — | SEC Form D |
| Debt Financing | Dec 2017 | $1.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Alleviant Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jacob KriegelDirectorSEC Form D
Avni PatelExecutive Officer, DirectorSEC Form D
Christopher ArevalosExecutive Officer, DirectorSEC Form D
Albertien GreijdanusExecutive Officer, DirectorSEC Form D
Adam BermanExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Pacertool develops PaCRTool, a highly differentiated and proprietary solution to improve cardiac resynchronization therapy (CRT) in heart…

Discover proactive heart failure management with the FDA-approved Cordella platform that guides care and improves outcomes based on…

Evidence-based data that connects patients to optimal therapeutic interventions—whether in clinical trial or FDA-approved.

Redefining heart failure by enabling early & safe treatment - Puzzle Medical Devices® Inc. is a Canadian company specializing in the…

The Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improve quality…

Replacing Hearts. Restoring Lives. HEART FAILURE Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2…
News
Alleviant Medical: $90 Million Raised For Developing No-Implant Atrial Shunt For Heart Failure
Alleviant Medical - a privately held medical device company developing a no-implant atrial shunt for heart failure - announced a $90 million financing to fund its second pivotal trial. The round was led by Gilde Healthcare, and it also included Omega Fund
Read more
Report
Alleviant Medical secures $90m to launch pivotal aortic stent trial
The $90m will be used to launch the second of two pivotal trials examining the company's therapy for patients living with heart failure.
Read more
Report
Alleviant Medical wins IDE for no-implant atrial shunt device pivotal trial
The trial, which will involve around 350 patients with reduced ejection fraction, will begin enrolling in early 2025.
Read more
Report
Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population
Read more
Report
Alleviant Medical secures $75M for heart trial
Alleviant Medical raises $75 million to fund its ALLAY-HF trial, aiming to prove the safety and efficacy of a no-implant device for treating heart failure. This trial could offer a less invasive treatment option for millions of patients worldwide.
Read more
Report
Pro access
Upgrade to see all 9 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People

Jacob Kriegel
Director

Avni Patel
Executive Officer, Director

Christopher Arevalos
Executive Officer, Director

Albertien Greijdanus
Executive Officer, Director

Adam Berman
Executive Officer, Director

Maria Berkman
Director

Mary Byron
Director

Christopher Kaster
Director

Kirk Nielsen
Director

Ashok Gowda
Director

Brian Smith
Director

Gowda Ashok
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Houston
United States
HQ
Financials
Total raised
$161.8M
Latest round
Venture - Series Unknown
Funding rounds
5

Broadview Ventures